Shade Matching of Universal Versus Conventional Nanohybrid Resin Composites in Class IV Restorations After Bleaching
Launched by CAIRO UNIVERSITY · Nov 27, 2022
Trial Information
Current as of January 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well two types of dental materials match the color of teeth after a whitening treatment. The study compares a single shade universal resin composite to a traditional nanohybrid resin composite for filling in class IV restorations, which are repairs on the front teeth. The goal is to see which material does a better job at blending in with the natural tooth color after teeth whitening.
To participate, you should be between the ages of 18 and 75 and have one or more existing class IV restorations that need treatment. You also need to be okay with undergoing teeth whitening. However, this trial is not for everyone. People with serious health issues, certain dental problems, or those who smoke will not be eligible. If you join the study, you can expect to have your dental restoration done with one of the materials being tested, and your experience will help researchers understand which option is better for achieving a natural look after whitening.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Candidates must have one or more existing class IV restoration.
- • Cases indicated for bleaching.
- • Cooperative patient approving to participate in the trial.
- Exclusion Criteria:
- • Patients with severe medical conditions that might interfere with the study.
- • Patients with rampant caries or xerostomia.
- • Smoking.
- • Patients with history of hydrogen peroxide sensitivity , periodontal inflammation.
- • Lack of compliance.
- • Tempromandibular joint disorders.
- • Disabilities.
Trial Officials
ahmed El Zoheiry, prof
Study Director
Cairo University
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials